WHO ICTRP trial
Study for mTOR Inhibitor as Adjunctive Therapy in children With Cerebral…
ChiCTR1900021288 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900021288 |
|---|---|
| Public title | Study for mTOR Inhibitor as Adjunctive Therapy in children With Cerebral Adrenoleukodystrophy |
| Scientific title | Study for mTOR Inhibitor as Adjunctive Therapy in children With Cerebral Adrenoleukodystrophy |
| Primary sponsor | Beijing JingDu Children's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | X-linked adrenomyeloneuropathy |
| Interventions | Case series:mTOR inhibitor |
| Registration date | Feb 11, 2019 |
| Target size | Case series:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: